NAP1L1 and hepatocellular carcinoma: Moreover, TCGA data (https://www.proteinatlas.org/) also indicated that patients with high NAP1L1 expression predicted reduced OS of HCC patients (p < 0.001) (Fig. 1d, right) compared to those with low NAP1L1 expression.